Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Bayer Schering Launches MS Drug Betaferon

publication date: Sep 27, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Bayer Schering announced the China launch of Betaferon® (interferon beta-1b), a treatment for relapsing-remitting forms of multiple sclerosis (MS). The drug received SFDA approval for distribution in China last December. Bayer has introduced several products recently as it strives to make good on its promise to increase its revenues at a better than 20% rate. More details....

Stock Symbol: (XETRA: BAY)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners